Literatura científica selecionada sobre o tema "Cancer du sein – radiothérapie"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Índice
Consulte a lista de atuais artigos, livros, teses, anais de congressos e outras fontes científicas relevantes para o tema "Cancer du sein – radiothérapie".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Artigos de revistas sobre o assunto "Cancer du sein – radiothérapie"
da Silva, Jonatas Gomes Barbosa, Diogo Timóteo Costa, Iago Dillion Lima Cavalcanti, Mariane Cajubá de Britto Lira Nogueira e Diego Augusto de Oliveira. "Qualité de vie des femmes atteintes du cancer du sein traitées dans un centre de radiothérapie à Caruaru, Pernambuco, Brésil". Canadian Oncology Nursing Journal 32, n.º 2 (21 de abril de 2022): 172–81. http://dx.doi.org/10.5737/23688076322172181.
Texto completo da fonteSchneider, M. "Radiothérapie et cancer du sein". Oncologie 19, n.º 3-4 (abril de 2017): 92–94. http://dx.doi.org/10.1007/s10269-017-2695-z.
Texto completo da fonteHennequin, C., I. Barillot, D. Azria, Y. Belkacémi, M. Bollet, B. Chauvet, D. Cowen et al. "Radiothérapie du cancer du sein". Cancer/Radiothérapie 20 (setembro de 2016): S139—S146. http://dx.doi.org/10.1016/j.canrad.2016.07.025.
Texto completo da fonteKeita, M., A. Toure, I. Camara, A. Barry, M. Koulibaly e B. Traore. "C98: Impact de la chirurgie associée à la radiothérapie sur le pronostic du cancer du sein en Guinée : Etude cohorte des cancers du sein de Guinée". African Journal of Oncology 2, n.º 1 Supplement (1 de março de 2022): S41—S42. http://dx.doi.org/10.54266/ajo.2.1s.c98.jdql5963.
Texto completo da fonteDilhuydy, J. M., E. Luporsi, L. Leichtnam-Dugarin, P. Vennin e H. Hoarau. "La radiothérapie du cancer du sein". Cancer/Radiothérapie 7, n.º 3 (junho de 2003): 213–21. http://dx.doi.org/10.1016/s1278-3218(03)00038-6.
Texto completo da fonteBourgier, Céline, Claire Lemanski, Pascal Fenoglietto, Olivier Riou, Jean Bernard Dubois e David Azria. "Radiothérapie partielle du sein". Bulletin du Cancer 101, n.º 1 (janeiro de 2014): 52–55. http://dx.doi.org/10.1684/bdc.2013.1869.
Texto completo da fonteBourgier, Céline, Claire Lemanski, Gilles Romieu, Mahmut Ozsahin e David Azria. "Cancer du sein : radiothérapie et signalisation œstrogénique". Bulletin du Cancer 101, n.º 7-8 (julho de 2014): 714–17. http://dx.doi.org/10.1684/bdc.2014.1954.
Texto completo da fonteJardel, Pauline, Zenab Alami, Stéphane Vignot, Anne Creisson, Serge Danhier, Julien Geffrelot, Christelle Levy, Emmanuel Kammerer, Jean François Lebrun e Juliette Thariat. "Radiothérapie des cancers du sein inflammatoires". Bulletin du Cancer 105, n.º 4 (abril de 2018): 415–25. http://dx.doi.org/10.1016/j.bulcan.2017.12.008.
Texto completo da fonteSarr, FN, PM Gaye, MB Ba, F. Niang, M. Mané e FCA Chemega. "C71: Métastases naso-sinusiennes du cancer du sein : A propos de deux cas". African Journal of Oncology 2, n.º 1 Supplement (1 de março de 2022): S30—S31. http://dx.doi.org/10.54266/ajo.2.1s.c71.cchk6379.
Texto completo da fontePrié, L., P. Lagarde, J. Palussière, S. El Ayoubi, JM Dilhuydy, M. Durand e G. Kantor. "Radiothérapie de métastases vertébrales du cancer du sein". Bulletin du Cancer/Radiothérapie 83, n.º 4 (janeiro de 1996): 306. http://dx.doi.org/10.1016/s0924-4212(97)86077-x.
Texto completo da fonteTeses / dissertações sobre o assunto "Cancer du sein – radiothérapie"
Baudier, Philippe. "Les cancers du sein de type III traités par radiothérapie et chirurgie partielle". Montpellier 1, 1990. http://www.theses.fr/1990MON11276.
Texto completo da fonteSalomon, Alain. "Radiothérapie à visée exclusive dans le traitement du cancer du sein : à propos de 186 cas". Montpellier 1, 1989. http://www.theses.fr/1989MON11340.
Texto completo da fonteGasiot-Bessiere, Elisabeth. "La contribution du scanner-simulateur dans l'optimisation de la balistique d'irradiation des cancers du sein". Montpellier 1, 1997. http://www.theses.fr/1997MON11076.
Texto completo da fonteBrulin-Lemanski, Claire. "Récidives locales des cancers du sein après traitement conservateur par chirurgie-radiothérapie : facteurs de risque et conséquences des échecs locaux à propos de 423 cas". Montpellier 1, 1997. http://www.theses.fr/1997MON11037.
Texto completo da fonteBouzid, Dounia. "Simulation Monte Carlo GATE et dosimétrie en radiothérapie peropératoire pour le cancer du sein". Thesis, Brest, 2015. http://www.theses.fr/2015BRES0065.
Texto completo da fonteExternal radiation therapy is an important part of breast conservative treatment. The conventional calendar is to deliver a total dose of 50 Gy in 25 fractions over 5 weeks. For certain categories of women, 5 to 6 weeks of radiotherapy, with long and frequent transport is sometimes difficult to achieve. Intra-operative radiotherapy (IORT) helps to prevent the risk of local recurrence in the tumor bed, and only requires a few days of hospitalization. This study focuses on the use of a miniaturized low energy X-ray source (50kV). After surgical resection of the tumor, an applicator is inserted into the tumor bed and the system delivers a single dose of 20 Gy on its surface. However, there is no custom prescription and this is questionable since an official text recommends optimizing the individual dose. In this context, a Monte Carlo calculation makes it possible to accurately assess the dose delivered to the patient by simulating the transport of particles. This thesis proposes to assess the absorbed dose criterion as accurately as possible from a realistic model of the X-ray source and individual dose calculations using Monte Carlo simulations taking into account the tissue heterogeneities of the breast. In vivo dosimetric measurements also confirm the results of simulations
Lemay, Rosalie. "Développement de nouveaux radiosensibilisateurs bromés pour la thérapie des cellules cancéreuses du sein". Mémoire, Université de Sherbrooke, 2006. http://savoirs.usherbrooke.ca/handle/11143/3853.
Texto completo da fonteCavalier, Isabelle Collard. "Apport du lambeau du grand dorsal dans la chirurgie reconstructrice de la paroi thoracique : à propos de 41 cas traités au CRLC de Montpellier entre 1986 et 1990". Montpellier 1, 1990. http://www.theses.fr/1990MON11147.
Texto completo da fonteTo, Nhu Hanh. "Effet des radiations ionisantes sur le système immunitaire de l'hôte et de la tumeur dans un modèle murin d'allogreffe et des cancers du sein localement avancés". Electronic Thesis or Diss., Paris 12, 2022. http://www.theses.fr/2022PA120071.
Texto completo da fonteRadiotherapy (RT) is one of the main therapies for cancer treatment. Currently, in France, it is estimated that approximately 200,000 patients receive RT each year for different stages of the disease.The impact of RT on the immune system has been recognized for several decades for its "myeloablative" effect in patients who are candidates for bone marrow transplant (BMT), but also in victims of nuclear accidents and atomic bomb explosions who suffered from fatal bone marrow failure. Regarding therapeutic potentials, immunostimulatory effects of RT have been reported under the term "abscopal effect," corresponding to antitumor responses after RT in non-irradiated sites distant from solid tumors.My work in the laboratory(I-BIOT team of the IMRB) focused on the modulation of the immune response applied to allografts and cancer in the two following models:1. Allograft mouse model: understanding the parameters of total body irradiation (TBI) is essential for the reproducibility and reliability of experimental results in mouse models. Data from the literature have shown considerable variation in the reproduction of the results between experiments depending on the device used to deliver the ICT before BMT. The objective of this work was to compare two types of irradiation devices using different energy levels regarding post-allograft results (chimerism, graft-versus-host disease, and post-transplant tumor control). We demonstrated that TBI with low-energy photons induced more post-TBI inflammation than high-energy photons and, therefore, more post-BMT alloreactivity. This inflammation could be modulated by delaying the graft outside of the inflammatory peak and thus reducing post-BMT alloreactivity. These data should be taken into consideration for the interpretation of the results obtained according to the type of device used in the experimental model.2. Clinical model of breast cancer: the 2nd work is part of a translational study of a prospective clinical trial evaluating the place of preoperative radiotherapy (RT) in triple-negative and luminal B breast cancer. These subtypes of breast cancer are well known for their aggressiveness and their immunogenicity. In this model, the preoperative RT aimed to increase tumor responses by acting on tumor immunity. Immunity-related biomarkers derived from tumor microenvironment and peripheral blood were analyzed. In a preliminary analysis of 42 patients, we identified different potential biomarkers associated with pathologic complete response according to the preoperative therapy administered (with or without RT). These results might help to better select patients individually for this new therapeutic approach
Dommesent, Damien. "Le cancer du sein inflammatoire : à propos de 40 patientes traitées au Centre François Baclesse entre 1987 et 1992". Caen, 1993. http://www.theses.fr/1993CAEN3072.
Texto completo da fonteLacombe, Jérôme. "Identification de biomarqueurs par approche protéomique : application au diagnostic des formes précoces de cancer du sein et à la réaction des tissus sains aux rayonnements ionisants". Thesis, Montpellier 1, 2013. http://www.theses.fr/2013MON1T031.
Texto completo da fonteBreast cancer is a major public health problem. With 500,000 deaths every year around the world, it focuses on many efforts in the search for new therapies and for therapeutic monitoring, diagnosis or prognosis biomarkers. From a diagnostic point of view, mammography remains gold standard for breast cancer detection. However, it has many limitations, especially in women with significant breast density. The identification of biomarkers for early diagnosis or for prognosis of in situ tumors in this population at risk would be a valuable improvement in the breast cancer management. Considering treatment strategies, radiotherapy has become a major treatment against breast cancer. However, some patients can develop severe radiation-induced late side effects. Their prediction is a main challenge as clinicians will be able to identify patients at risk and develop individualized treatment. Despite all efforts, no biomarkers are validated and used in clinical routine for normal tissues outcomes after irradiation. The aim of my PhD work was to identify protein markers for the diagnosis and prognosis of early-stage breast cancers, and also for the prediction of radiation-induced severe late effects. With different proteomic approaches, I was able to identify three protein signatures: (1) a serum autoantibody signature for the diagnosis of DCIS and node negative early-stage breast cancers (GAL3, RACK1, PAK2, and PHB2 RUVBL1), (2) a serum autoantibody signature of ductal carcinoma in situ progression to invasive breast cancer (CIRBP, ECHDC1, HMGN1, PSRC1 and RBP-Jκ) and (3) five lymphocyte proteins (AK2, ANX1, APEX1, HSPA8 and IDH2 ) that could predict late radiation-induced toxicity. In addition, these signatures allowed to identify new molecular partners likely to be involved in the mechanisms of mammary carcinogenesis and in the late radio-induced toxicity
Livros sobre o assunto "Cancer du sein – radiothérapie"
International SELECTRON Users' Meeting (5th 1988 The Hague). Brachytherapy 2: Proceedings of the 5th International SELECTRON Users' Meeting 1988 The Hague-The Netherlands. Editado por Mould R. F. 1939-. Leersum: Nucletron, 1989.
Encontre o texto completo da fonteJean-Jacques, Mazeron, ed. Techniques d'irradiation des cancers: La radiothérapie conformationnelle. 2a ed. Paris: Maloine, 2005.
Encontre o texto completo da fonteNamer, Moïse, Michel Héry, Daniel Serin, Marc Spielmann e Joseph Gligorov. Cancer du sein. Paris: Springer Paris, 2007. http://dx.doi.org/10.1007/978-2-287-71478-8.
Texto completo da fonteGros, Dominique. Cancer du sein. Paris: Springer Paris, 2009. http://dx.doi.org/10.1007/978-2-287-79503-9.
Texto completo da fonteNamer, Moïse, Michel Héry, Daniel Serin e Marc Spielmann. Cancer du sein. Paris: Springer Paris, 2006. http://dx.doi.org/10.1007/2-287-31109-2.
Texto completo da fonteNamer, Moïse, Michel Héry, Marc Spielmann, Joseph Gligorov e Frédérique Penault-Llorca. Cancer du sein. Paris: Springer Paris, 2012. http://dx.doi.org/10.1007/978-2-8178-0245-9.
Texto completo da fonteDixon, J. M. Cancer du sein. Montréal, Québec: Modus vivendi, 2014.
Encontre o texto completo da fonteHirshaut, Yashar. Cancer du sein. Paris: Marabout, 2004.
Encontre o texto completo da fontees, Socie te franc ʹaise de se nologie et de pathologie mammaire Journe. Cancer du sein avance. Paris: Springer, 2007.
Encontre o texto completo da fonteSerin, Daniel, e Gaëtan de Rauglaudre. Cancer du sein avancé. Paris: Springer Paris, 2007. http://dx.doi.org/10.1007/978-2-287-72615-6.
Texto completo da fonteCapítulos de livros sobre o assunto "Cancer du sein – radiothérapie"
Bourgier, Céline, e Steve Heymann. "Facteurs de décisions en radiothérapie". In Diagnostic et décision dans le cancer du sein à un stade précoce, 73–85. Paris: Springer Paris, 2012. http://dx.doi.org/10.1007/978-2-8178-0253-4_6.
Texto completo da fonteSarfati, I., A. Duvernay, C. Nos e K. B. Clough. "Lipofilling avant reconstruction par prothèse : une alternative aux lambeaux musculo-cutanés après mastectomie et radiothérapie pariétale". In Cancer du sein : surdiagnostic, surtraitement, 394–95. Paris: Springer Paris, 2012. http://dx.doi.org/10.1007/978-2-8178-0249-7_123.
Texto completo da fonteVieillot, S., C. Bourgier e D. Azria. "Techniques innovantes en radiothérapie, description et application aux cancers du sein métastatique (hors métastases cérébrales)". In Cancer du sein en situation métastatique, 59–68. Paris: Springer Paris, 2010. http://dx.doi.org/10.1007/978-2-8178-0076-9_7.
Texto completo da fonteGirard, N., e F. Mornex. "Chimiothérapie et radiothérapie des cancers pancréatiques". In Thérapeutique du cancer, 415–24. Paris: Springer Paris, 2011. http://dx.doi.org/10.1007/978-2-8178-0021-9_26.
Texto completo da fonteAzria, David, e Mahmut Ozsahin. "Complications tardives de la radiothérapie". In Aider á vivre aprés un cancer, 213–21. Paris: Springer Paris, 2010. http://dx.doi.org/10.1007/978-2-287-79501-5_16.
Texto completo da fonteDomblides, C., J. Mendiboure, G. Macgrogan, C. Tunon de Lara, P. Lagarde, C. Breton-Callu, V. Brouste e M. Debled. "Score prédictif de l’envahissement de la chaîne mammaire interne et/ou sus-claviculaire dans les cancers du sein des quadrants internes N0 : aide à la décision pour la radiothérapie". In Acquis et limites en sénologie / Assets and limits in breast diseases, 500–502. Paris: Springer Paris, 2013. http://dx.doi.org/10.1007/978-2-8178-0396-8_119.
Texto completo da fonteSauvage, M., B. Trétarre, P. Grosclaude, F. Molinié, A. M. Aude, A. Danzon, A. V. Guizard e P. Arveux. "Sein". In Survie des patients atteints de cancer en France, 225–32. Paris: Springer Paris, 2007. http://dx.doi.org/10.1007/978-2-287-39310-5_30.
Texto completo da fonteJaffré, I., V. Bordes, M. Dejode, F. Dravet e J. M. Classe. "État de l’art des recommandations actuelles sur les marges de sécurité nécessaires lors de l’exérèse conservatrice d’un cancer du sein". In Cancer du sein, 1–13. Paris: Springer Paris, 2012. http://dx.doi.org/10.1007/978-2-8178-0245-9_1.
Texto completo da fonteAlran, S. "Quelle place pour le ganglion sentinelle après chimiothérapie néo-adjuvante? Place d’un score clinico-biologique d’aide à la décision de ganglion sentinelle après chimiothérapie néo-adjuvante chez les patientes ayant un cancer du sein". In Cancer du sein, 127–33. Paris: Springer Paris, 2012. http://dx.doi.org/10.1007/978-2-8178-0245-9_10.
Texto completo da fonteBarreau, B., F. Ettore, S. Giard, J. M. Hannoun-Levi, K. Kerrou e O. Tredan. "Prise en charge de la récidive homolatérale d’un cancer du sein après traitement conservateur initial". In Cancer du sein, 135–64. Paris: Springer Paris, 2012. http://dx.doi.org/10.1007/978-2-8178-0245-9_11.
Texto completo da fonteTrabalhos de conferências sobre o assunto "Cancer du sein – radiothérapie"
Melka, A. C. "Retentissement sur l’état bucco-dentaire et la qualité de vie des patients avec un cancer de la cavité buccale ou de l’oropharynx traits par radiothérapie conformationnelle tridimensionnelle versus avec modulation d’intensité : à propos de 52 cas". In 66ème Congrès de la SFCO. Les Ulis, France: EDP Sciences, 2020. http://dx.doi.org/10.1051/sfco/20206603012.
Texto completo da fonteFongaufier, C., S. Zahouily, CI Gros, S. Guihard, F. Hubelé, P. Barthélémy e F. Bornert. "Métastases mandibulaires du cancer du sein, aspects diagnostiques et thérapeutiques : réflexion autour de 3 cas". In 65ème Congrès de la SFCO. Les Ulis, France: EDP Sciences, 2017. http://dx.doi.org/10.1051/sfco/20176502024.
Texto completo da fonteDesbrée, Aurélie. "Evaluation de la dose en médecine nucléaire dans le cas d’un traitement par radiothérapie vectorisée : le cas du cancer du foie". In La compétitivité des technologies bas carbone de production de l’électricité. Les Ulis, France: EDP Sciences, 2016. http://dx.doi.org/10.1051/jtsfen/2016rad05.
Texto completo da fonteRichard, Amélie, Karen Reilly e Sophie Jacquin-Courtois. "Que révèlent les disfluences sur le manque du mot rapporté par les patientes ayant un cancer du sein". In XXXIVe Journées d'Études sur la Parole -- JEP 2022. ISCA: ISCA, 2022. http://dx.doi.org/10.21437/jep.2022-38.
Texto completo da fonteAnxionnat, C., MA Fauroux, C. Favre de Thierrens, P. Boisselier e JH Torres. "Etude prospective de la prise en charge bucco-dentaire de 51 patients atteints d’un cancer des voies aériennes digestives supérieures avant radiothérapie maxillo-faciale". In 62ème Congrès de la SFCO. Les Ulis, France: EDP Sciences, 2014. http://dx.doi.org/10.1051/sfco/20146202007.
Texto completo da fonteHascoet, E., G. Valette, G. Le Toux e S. Boisramé. "Proposition d’un protocole de prise en charge implanto-portée de patients traités en oncologie tête et cou suite à une étude rétrospective au CHRU de Brest". In 66ème Congrès de la SFCO. Les Ulis, France: EDP Sciences, 2020. http://dx.doi.org/10.1051/sfco/20206602009.
Texto completo da fonteRelatórios de organizações sobre o assunto "Cancer du sein – radiothérapie"
Corkum, Eleanor, Tiffanie Perrault e Erin C. Strumpf. Améliorer les parcours de diagnostic du cancer du sein au Québec. CIRANO, outubro de 2023. http://dx.doi.org/10.54932/tlak9928.
Texto completo da fonte